VIVIANA FAUNCE: Open Payments
NPI 1780056127 · ATLANTIC CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$230 in 12 payments from 8 companies in 2025. Trend: 2023 $284 · 2024 $131 · 2025 $230
Food & beverage: $230
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $67 |
| TG Therapeutics, Inc. | 2 | $42 |
| Biogen, Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| EMD Serono, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: UBRELVY, BRIUMVI, LEQEMBI, REXULTI, AUSTEDO XR, Ocrevus Zunovo, QULIPTA, UPLIZNA.
Industry payments across NJ — which companies pay providers there.
